Cigna Group
XMUN:CGN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
240.3
338.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cigna Group
Other Items
Cigna Group
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cigna Group
XMUN:CGN
|
Other Items
-$917m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
48%
|
CAGR 10-Years
6%
|
|
|
DaVita Inc
NYSE:DVA
|
Other Items
-$148m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Items
-$1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-9%
|
|
|
CVS Health Corp
NYSE:CVS
|
Other Items
-$5.4B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
34%
|
CAGR 10-Years
-13%
|
|
|
Cigna Corp
NYSE:CI
|
Other Items
-$917m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
48%
|
CAGR 10-Years
6%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Items
-$942.8m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-25%
|
|
Cigna Group
Glance View
Cigna Group, a prominent global health service company, has carved out a significant niche in the ever-evolving landscape of healthcare and insurance. With roots tracing back to the 1980s, Cigna's mission is to enhance the health, wellness, and peace of mind for its customers through a diverse array of products and services. Today, the company serves millions of customers worldwide, offering a robust portfolio that includes health insurance, disability, life insurance, and managed care solutions. As the healthcare landscape becomes increasingly complex, Cigna stands out through its innovative approach to care coordination and a focus on preventive solutions that address not just the symptoms but the underlying factors affecting health. From an investor's perspective, Cigna Group presents a compelling opportunity. The company has demonstrated strong financial stability and growth potential, underpinned by strategic acquisitions, like the significant purchase of Express Scripts, which expanded its capabilities in pharmacy benefits management. Cigna's commitment to integrating digital technology into healthcare services, alongside its focus on value-based care, positions it well amidst rising healthcare costs and an aging population that demands more personalized care solutions. With a solid track record of revenue growth, consistent shareholder returns, and a forward-thinking leadership team, Cigna Group offers investors a unique blend of resilience, adaptability, and long-term value in an increasingly important sector.
See Also
What is Cigna Group's Other Items?
Other Items
-917m
USD
Based on the financial report for Sep 30, 2024, Cigna Group's Other Items amounts to -917m USD.
What is Cigna Group's Other Items growth rate?
Other Items CAGR 10Y
6%
Over the last year, the Other Items growth was 76%.
You don't have any saved screeners yet
